Navigation Links
Stent Effective In Keeping Arteries Open

A new type of stent that releases medication appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, // a process known as restenosis. The experimental stent, a mesh tube, releases the immunosuppressant drug everolimus. The drug acts by inhibiting cell reproduction and reducing cell growth in vessel walls. Unlike other similar drug-eluting stents, the one used in this study is made with a biodegradable polymer researchers believe will reduce and minimize long-term inflammation and restenosis.

This unique everolimus-coated stent freezes the biological process that leads to the renarrowing of arteries after catheter-based treatments. Not only are the patients free from symptoms, but they have open arteries 12 months after stent implantation. Results of the study show patients who received the everolimus-coated stents had 87-percent less narrowing in the treated portion of their arteries than those who received uncoated, or bare-metal, stents.

Of the 42 patients in the study, 27 received the new stents and 15 received standard stents. Standard stents have metal mesh tubes used to keep vessels open after balloon angioplasty opens the clogged artery. Everolimus also has promise in preventing heart and kidney rejection after transplantation.
'"/>




Page: 1

Related medicine news :

1. Stent shows promise in keeping arteries open
2. Failure of Drug-Coated Stent
3. Drug-Coated Stent
4. Stronger Backing for Drug-Coated Stents
5. Drug-Coated Stents – Proven to be More Effectiv
6. The Efficacy Of Newer Stents Questioned
7. Analyzing The Side Effects Of Sirolimus Stents
8. Stents That Release Medication To Check Artery Narrowing
9. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
10. Stenting: A Possible Remedy For Brain Artery Blockage
11. Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... Dr. Ronald E. Hawkins, vice president for academic affairs ... Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of Liberty ... to Liberty from the Ohio University Heritage College of Osteopathic Medicine (OU-HCOM), where ...
(Date:2/24/2017)... ... ... With millions of Americans and people worldwide struggling with ... aware of our options and are empowered with strength and information throughout the ... newest edition of "Vision and Hearing" in USA Today, that will educate readers ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users ... X . Users have total control over position, rotation, distortion, edge softness, edge blur, ... Final Cut Pro X. , With ProGlass Prism users are given the tools ...
(Date:2/24/2017)... IL (PRWEB) , ... February 24, 2017 , ... The ... the 7th annual “Imagine Me Beyond What You See” body image mannequin art competition. ... Choice will be showcased and the winner revealed at the 31st annual iaedp Symposium, ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... and PETACH TIKVAH, Israel , ... (NASDAQ: BCLI), a leading developer of adult stem cell ... June S. Almenoff , M.D., Ph.D., FACP, and ... Board of Directors.  "Dr. Almenoff and ... appointments come at an exciting time for our company," ...
(Date:2/24/2017)... Following receiving CE Marking in ... AMAR is a major milestone for the country where the device was ... market in Israel   ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets ... Strategies - 2016" report to their offering. ... The latest research Hemophilia Drugs Price Analysis and ... Hemophilia market. The research answers the following questions: ... clinical attributes? How are they positioned in the Global Hemophilia market? ...
Breaking Medicine Technology: